Global Ketorolac Tromethamine Market Research Report 2023

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.

The global Ketorolac Tromethamine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Ketorolac Tromethamine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Ketorolac Tromethamine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Ketorolac Tromethamine include Pfizer, Omeros Corporation, Egalet US Inc., Allergan, Dr. Reddy’s Laboratories, Teva, Mylan, West Ward Pharmaceuticals and Fresenius Kabi, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Ketorolac Tromethamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Tromethamine.

The Ketorolac Tromethamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ketorolac Tromethamine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ketorolac Tromethamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Ketorolac Tromethamine

1.2 Ketorolac Tromethamine Segment by Type

1.2.1 Global Ketorolac Tromethamine Market Value Comparison by Type (2023-2029)

1.2.2 Injection

1.2.3 Ophthalmic

1.2.4 Nasal

1.2.5 Oral tablet

1.3 Ketorolac Tromethamine Segment by Application

1.3.1 Global Ketorolac Tromethamine Market Value by Application: (2023-2029)

1.3.2 Short-term treatment of pain

1.3.3 Ophthalmic Surgery

1.4 Global Ketorolac Tromethamine Market Size Estimates and Forecasts

1.4.1 Global Ketorolac Tromethamine Revenue 2018-2029

1.4.2 Global Ketorolac Tromethamine Sales 2018-2029

1.4.3 Global Ketorolac Tromethamine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Ketorolac Tromethamine Average Price by Manufacturers (2018-2023)

2.4 Global Ketorolac Tromethamine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Ketorolac Tromethamine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ketorolac Tromethamine, Product Type & Application

2.7 Ketorolac Tromethamine Market Competitive Situation and Trends

2.7.1 Ketorolac Tromethamine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Ketorolac Tromethamine Players Market Share by Revenue

2.7.3 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Ketorolac Tromethamine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Ketorolac Tromethamine Global Ketorolac Tromethamine Sales by Region: 2018-2029

3.2.1 Global Ketorolac Tromethamine Sales by Region: 2018-2023

3.2.2 Global Ketorolac Tromethamine Sales by Region: 2024-2029

3.3 Global Ketorolac Tromethamine Global Ketorolac Tromethamine Revenue by Region: 2018-2029

3.3.1 Global Ketorolac Tromethamine Revenue by Region: 2018-2023

3.3.2 Global Ketorolac Tromethamine Revenue by Region: 2024-2029

3.4 North America Ketorolac Tromethamine Market Facts & Figures by Country

3.4.1 North America Ketorolac Tromethamine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Ketorolac Tromethamine Sales by Country (2018-2029)

3.4.3 North America Ketorolac Tromethamine Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ketorolac Tromethamine Market Facts & Figures by Country

3.5.1 Europe Ketorolac Tromethamine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Ketorolac Tromethamine Sales by Country (2018-2029)

3.5.3 Europe Ketorolac Tromethamine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Country

3.6.1 Asia Pacific Ketorolac Tromethamine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Ketorolac Tromethamine Sales by Country (2018-2029)

3.6.3 Asia Pacific Ketorolac Tromethamine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ketorolac Tromethamine Market Facts & Figures by Country

3.7.1 Latin America Ketorolac Tromethamine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Ketorolac Tromethamine Sales by Country (2018-2029)

3.7.3 Latin America Ketorolac Tromethamine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Country

3.8.1 Middle East and Africa Ketorolac Tromethamine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Ketorolac Tromethamine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Ketorolac Tromethamine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Ketorolac Tromethamine Sales by Type (2018-2029)

4.1.1 Global Ketorolac Tromethamine Sales by Type (2018-2023)

4.1.2 Global Ketorolac Tromethamine Sales by Type (2024-2029)

4.1.3 Global Ketorolac Tromethamine Sales Market Share by Type (2018-2029)

4.2 Global Ketorolac Tromethamine Revenue by Type (2018-2029)

4.2.1 Global Ketorolac Tromethamine Revenue by Type (2018-2023)

4.2.2 Global Ketorolac Tromethamine Revenue by Type (2024-2029)

4.2.3 Global Ketorolac Tromethamine Revenue Market Share by Type (2018-2029)

4.3 Global Ketorolac Tromethamine Price by Type (2018-2029)

5.1 Global Ketorolac Tromethamine Sales by Application (2018-2029)

5.1.1 Global Ketorolac Tromethamine Sales by Application (2018-2023)

5.1.2 Global Ketorolac Tromethamine Sales by Application (2024-2029)

5.1.3 Global Ketorolac Tromethamine Sales Market Share by Application (2018-2029)

5.2 Global Ketorolac Tromethamine Revenue by Application (2018-2029)

5.2.1 Global Ketorolac Tromethamine Revenue by Application (2018-2023)

5.2.2 Global Ketorolac Tromethamine Revenue by Application (2024-2029)

5.2.3 Global Ketorolac Tromethamine Revenue Market Share by Application (2018-2029)

5.3 Global Ketorolac Tromethamine Price by Application (2018-2029)

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Pfizer Ketorolac Tromethamine Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Omeros Corporation

6.2.1 Omeros Corporation Corporation Information

6.2.2 Omeros Corporation Description and Business Overview

6.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio

6.2.5 Omeros Corporation Recent Developments/Updates

6.3 Egalet US Inc.

6.3.1 Egalet US Inc. Corporation Information

6.3.2 Egalet US Inc. Description and Business Overview

6.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio

6.3.5 Egalet US Inc. Recent Developments/Updates

6.4 Allergan

6.4.1 Allergan Corporation Information

6.4.2 Allergan Description and Business Overview

6.4.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Allergan Ketorolac Tromethamine Product Portfolio

6.4.5 Allergan Recent Developments/Updates

6.5 Dr. Reddy’s Laboratories

6.5.1 Dr. Reddy’s Laboratories Corporation Information

6.5.2 Dr. Reddy’s Laboratories Description and Business Overview

6.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio

6.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates

6.6 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Teva Ketorolac Tromethamine Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Mylan

6.6.1 Mylan Corporation Information

6.6.2 Mylan Description and Business Overview

6.6.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Mylan Ketorolac Tromethamine Product Portfolio

6.7.5 Mylan Recent Developments/Updates

6.8 West Ward Pharmaceuticals

6.8.1 West Ward Pharmaceuticals Corporation Information

6.8.2 West Ward Pharmaceuticals Description and Business Overview

6.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Product Portfolio

6.8.5 West Ward Pharmaceuticals Recent Developments/Updates

6.9 Fresenius Kabi

6.9.1 Fresenius Kabi Corporation Information

6.9.2 Fresenius Kabi Description and Business Overview

6.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Fresenius Kabi Ketorolac Tromethamine Product Portfolio

6.9.5 Fresenius Kabi Recent Developments/Updates

6.10 Apotex

6.10.1 Apotex Corporation Information

6.10.2 Apotex Description and Business Overview

6.10.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Apotex Ketorolac Tromethamine Product Portfolio

6.10.5 Apotex Recent Developments/Updates

6.11 Sandoz

6.11.1 Sandoz Corporation Information

6.11.2 Sandoz Ketorolac Tromethamine Description and Business Overview

6.11.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Sandoz Ketorolac Tromethamine Product Portfolio

6.11.5 Sandoz Recent Developments/Updates

6.12 Amphastar Pharmaceuticals

6.12.1 Amphastar Pharmaceuticals Corporation Information

6.12.2 Amphastar Pharmaceuticals Ketorolac Tromethamine Description and Business Overview

6.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio

6.12.5 Amphastar Pharmaceuticals Recent Developments/Updates

6.13 Gland Pharma Limited

6.13.1 Gland Pharma Limited Corporation Information

6.13.2 Gland Pharma Limited Ketorolac Tromethamine Description and Business Overview

6.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio

6.13.5 Gland Pharma Limited Recent Developments/Updates

6.14 Akorn

6.14.1 Akorn Corporation Information

6.14.2 Akorn Ketorolac Tromethamine Description and Business Overview

6.14.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Akorn Ketorolac Tromethamine Product Portfolio

6.14.5 Akorn Recent Developments/Updates

6.15 Sun Pharmaceutical

6.15.1 Sun Pharmaceutical Corporation Information

6.15.2 Sun Pharmaceutical Ketorolac Tromethamine Description and Business Overview

6.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio

6.15.5 Sun Pharmaceutical Recent Developments/Updates

6.16 Sagent Pharmaceuticals

6.16.1 Sagent Pharmaceuticals Corporation Information

6.16.2 Sagent Pharmaceuticals Ketorolac Tromethamine Description and Business Overview

6.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.16.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio

6.16.5 Sagent Pharmaceuticals Recent Developments/Updates

6.17 Aurobindo Pharma

6.17.1 Aurobindo Pharma Corporation Information

6.17.2 Aurobindo Pharma Ketorolac Tromethamine Description and Business Overview

6.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2018-2023)

6.17.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio

6.17.5 Aurobindo Pharma Recent Developments/Updates

7.1 Ketorolac Tromethamine Industry Chain Analysis

7.2 Ketorolac Tromethamine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ketorolac Tromethamine Production Mode & Process

7.4 Ketorolac Tromethamine Sales and Marketing

7.4.1 Ketorolac Tromethamine Sales Channels

7.4.2 Ketorolac Tromethamine Distributors

7.5 Ketorolac Tromethamine Customers

8.1 Ketorolac Tromethamine Industry Trends

8.2 Ketorolac Tromethamine Market Drivers

8.3 Ketorolac Tromethamine Market Challenges

8.4 Ketorolac Tromethamine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Ketorolac Tromethamine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Ketorolac Tromethamine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Ketorolac Tromethamine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Ketorolac Tromethamine Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Ketorolac Tromethamine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Ketorolac Tromethamine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Ketorolac Tromethamine Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Ketorolac Tromethamine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Ketorolac Tromethamine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Ketorolac Tromethamine, Product Type & Application

    Table 12. Global Key Manufacturers of Ketorolac Tromethamine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Ketorolac Tromethamine Sales by Region (2018-2023) & (K Units)

    Table 18. Global Ketorolac Tromethamine Sales Market Share by Region (2018-2023)

    Table 19. Global Ketorolac Tromethamine Sales by Region (2024-2029) & (K Units)

    Table 20. Global Ketorolac Tromethamine Sales Market Share by Region (2024-2029)

    Table 21. Global Ketorolac Tromethamine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Ketorolac Tromethamine Revenue Market Share by Region (2018-2023)

    Table 23. Global Ketorolac Tromethamine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Ketorolac Tromethamine Revenue Market Share by Region (2024-2029)

    Table 25. North America Ketorolac Tromethamine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Ketorolac Tromethamine Sales by Country (2018-2023) & (K Units)

    Table 27. North America Ketorolac Tromethamine Sales by Country (2024-2029) & (K Units)

    Table 28. North America Ketorolac Tromethamine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Ketorolac Tromethamine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Ketorolac Tromethamine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Ketorolac Tromethamine Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Ketorolac Tromethamine Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Ketorolac Tromethamine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Ketorolac Tromethamine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Ketorolac Tromethamine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Ketorolac Tromethamine Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Ketorolac Tromethamine Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Ketorolac Tromethamine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Ketorolac Tromethamine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Ketorolac Tromethamine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Ketorolac Tromethamine Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Ketorolac Tromethamine Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Ketorolac Tromethamine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Ketorolac Tromethamine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Ketorolac Tromethamine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Ketorolac Tromethamine Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Ketorolac Tromethamine Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Ketorolac Tromethamine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Ketorolac Tromethamine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Ketorolac Tromethamine Sales (K Units) by Type (2018-2023)

    Table 51. Global Ketorolac Tromethamine Sales (K Units) by Type (2024-2029)

    Table 52. Global Ketorolac Tromethamine Sales Market Share by Type (2018-2023)

    Table 53. Global Ketorolac Tromethamine Sales Market Share by Type (2024-2029)

    Table 54. Global Ketorolac Tromethamine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Ketorolac Tromethamine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Ketorolac Tromethamine Revenue Market Share by Type (2018-2023)

    Table 57. Global Ketorolac Tromethamine Revenue Market Share by Type (2024-2029)

    Table 58. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Ketorolac Tromethamine Sales (K Units) by Application (2018-2023)

    Table 61. Global Ketorolac Tromethamine Sales (K Units) by Application (2024-2029)

    Table 62. Global Ketorolac Tromethamine Sales Market Share by Application (2018-2023)

    Table 63. Global Ketorolac Tromethamine Sales Market Share by Application (2024-2029)

    Table 64. Global Ketorolac Tromethamine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Ketorolac Tromethamine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Ketorolac Tromethamine Revenue Market Share by Application (2018-2023)

    Table 67. Global Ketorolac Tromethamine Revenue Market Share by Application (2024-2029)

    Table 68. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2024-2029)

    Table 70. Pfizer Corporation Information

    Table 71. Pfizer Description and Business Overview

    Table 72. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Pfizer Ketorolac Tromethamine Product

    Table 74. Pfizer Recent Developments/Updates

    Table 75. Omeros Corporation Corporation Information

    Table 76. Omeros Corporation Description and Business Overview

    Table 77. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Omeros Corporation Ketorolac Tromethamine Product

    Table 79. Omeros Corporation Recent Developments/Updates

    Table 80. Egalet US Inc. Corporation Information

    Table 81. Egalet US Inc. Description and Business Overview

    Table 82. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Egalet US Inc. Ketorolac Tromethamine Product

    Table 84. Egalet US Inc. Recent Developments/Updates

    Table 85. Allergan Corporation Information

    Table 86. Allergan Description and Business Overview

    Table 87. Allergan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Allergan Ketorolac Tromethamine Product

    Table 89. Allergan Recent Developments/Updates

    Table 90. Dr. Reddy’s Laboratories Corporation Information

    Table 91. Dr. Reddy’s Laboratories Description and Business Overview

    Table 92. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product

    Table 94. Dr. Reddy’s Laboratories Recent Developments/Updates

    Table 95. Teva Corporation Information

    Table 96. Teva Description and Business Overview

    Table 97. Teva Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Teva Ketorolac Tromethamine Product

    Table 99. Teva Recent Developments/Updates

    Table 100. Mylan Corporation Information

    Table 101. Mylan Description and Business Overview

    Table 102. Mylan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Mylan Ketorolac Tromethamine Product

    Table 104. Mylan Recent Developments/Updates

    Table 105. West Ward Pharmaceuticals Corporation Information

    Table 106. West Ward Pharmaceuticals Description and Business Overview

    Table 107. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. West Ward Pharmaceuticals Ketorolac Tromethamine Product

    Table 109. West Ward Pharmaceuticals Recent Developments/Updates

    Table 110. Fresenius Kabi Corporation Information

    Table 111. Fresenius Kabi Description and Business Overview

    Table 112. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Fresenius Kabi Ketorolac Tromethamine Product

    Table 114. Fresenius Kabi Recent Developments/Updates

    Table 115. Apotex Corporation Information

    Table 116. Apotex Description and Business Overview

    Table 117. Apotex Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Apotex Ketorolac Tromethamine Product

    Table 119. Apotex Recent Developments/Updates

    Table 120. Sandoz Corporation Information

    Table 121. Sandoz Description and Business Overview

    Table 122. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. Sandoz Ketorolac Tromethamine Product

    Table 124. Sandoz Recent Developments/Updates

    Table 125. Amphastar Pharmaceuticals Corporation Information

    Table 126. Amphastar Pharmaceuticals Description and Business Overview

    Table 127. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. Amphastar Pharmaceuticals Ketorolac Tromethamine Product

    Table 129. Amphastar Pharmaceuticals Recent Developments/Updates

    Table 130. Gland Pharma Limited Corporation Information

    Table 131. Gland Pharma Limited Description and Business Overview

    Table 132. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 133. Gland Pharma Limited Ketorolac Tromethamine Product

    Table 134. Gland Pharma Limited Recent Developments/Updates

    Table 135. Akorn Corporation Information

    Table 136. Akorn Description and Business Overview

    Table 137. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 138. Akorn Ketorolac Tromethamine Product

    Table 139. Akorn Recent Developments/Updates

    Table 140. Sun Pharmaceutical Corporation Information

    Table 141. Sun Pharmaceutical Description and Business Overview

    Table 142. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 143. Sun Pharmaceutical Ketorolac Tromethamine Product

    Table 144. Sun Pharmaceutical Recent Developments/Updates

    Table 145. Sagent Pharmaceuticals Corporation Information

    Table 146. Sagent Pharmaceuticals Description and Business Overview

    Table 147. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 148. Sagent Pharmaceuticals Ketorolac Tromethamine Product

    Table 149. Sagent Pharmaceuticals Recent Developments/Updates

    Table 150. Aurobindo Pharma Corporation Information

    Table 151. Aurobindo Pharma Description and Business Overview

    Table 152. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 153. Aurobindo Pharma Ketorolac Tromethamine Product

    Table 154. Aurobindo Pharma Recent Developments/Updates

    Table 155. Key Raw Materials Lists

    Table 156. Raw Materials Key Suppliers Lists

    Table 157. Ketorolac Tromethamine Distributors List

    Table 158. Ketorolac Tromethamine Customers List

    Table 159. Ketorolac Tromethamine Market Trends

    Table 160. Ketorolac Tromethamine Market Drivers

    Table 161. Ketorolac Tromethamine Market Challenges

    Table 162. Ketorolac Tromethamine Market Restraints

    Table 163. Research Programs/Design for This Report

    Table 164. Key Data Information from Secondary Sources

    Table 165. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Ketorolac Tromethamine

    Figure 2. Global Ketorolac Tromethamine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Ketorolac Tromethamine Market Share by Type in 2022 & 2029

    Figure 4. Injection Product Picture

    Figure 5. Ophthalmic Product Picture

    Figure 6. Nasal Product Picture

    Figure 7. Oral tablet Product Picture

    Figure 8. Global Ketorolac Tromethamine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Ketorolac Tromethamine Market Share by Application in 2022 & 2029

    Figure 10. Short-term treatment of pain

    Figure 11. Ophthalmic Surgery

    Figure 12. Global Ketorolac Tromethamine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Ketorolac Tromethamine Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Ketorolac Tromethamine Sales (2018-2029) & (K Units)

    Figure 15. Global Ketorolac Tromethamine Average Price (USD/Unit) & (2018-2029)

    Figure 16. Ketorolac Tromethamine Report Years Considered

    Figure 17. Ketorolac Tromethamine Sales Share by Manufacturers in 2022

    Figure 18. Global Ketorolac Tromethamine Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Ketorolac Tromethamine Players: Market Share by Revenue in 2022

    Figure 20. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Ketorolac Tromethamine Sales Market Share by Country (2018-2029)

    Figure 23. North America Ketorolac Tromethamine Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Ketorolac Tromethamine Sales Market Share by Country (2018-2029)

    Figure 27. Europe Ketorolac Tromethamine Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region (2018-2029)

    Figure 35. China Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Ketorolac Tromethamine Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Ketorolac Tromethamine Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. U.A.E Ketorolac Tromethamine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Ketorolac Tromethamine by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Ketorolac Tromethamine by Type (2018-2029)

    Figure 57. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Ketorolac Tromethamine by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Ketorolac Tromethamine by Application (2018-2029)

    Figure 60. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2018-2029)

    Figure 61. Ketorolac Tromethamine Value Chain

    Figure 62. Ketorolac Tromethamine Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed